- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Virtual Event – Agitation Associated With Alzheimer’s Dementia (AAD) In The Long-Term Care (LTC) Setting
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Agitation Associated With Alzheimer’s Dementia (AAD) In The Long-Term Care (LTC) Setting
This review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) with a focus on those who are living with this condition or who are caring for those who live with this condition in the Long-Term Care (LTC) setting. This information is intended to help provide a better understanding of the implications of this disorder that are associated with it in the LTC environment including prevalence, medication use, costs of care and the challenges associated with antipsychotic use. It also describes the diagnostic criteria for AAD and explores the potential pathobiological correlations in AAD.
Objectives:
- Learn about agitation associated with Alzheimer’s Dementia (AAD) as a highly prevalent disorder that is present in all stages and severities for those with Alzheimer’s dementia
- Gain understanding about the potential pathobiological elements, and the associated neurotransmitters implicated with AAD
- Review information related to patient and care-giver burden as well as the healthcare utilization and costs associated with AAD
- Consider the class of antipsychotics and the challenges associated with using this class of medications in the Long-Term Care setting
Featuring
Craig Owens, RPh (OPDC)
Long Term Care Medical Science Liaison
Craig Owens, RPh is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Related Events
-
Identification of Agitation in Patients with Dementia due to Alzheimer’s Disease: Perspectives from the Primary Care Provider
December 18 12:00 pm to 1:00 pm
Registration
Log in to register
Related Resources
-
Addressing Caregiver Burden & Identifying Agitation in Alzheimer’s Dementia
On-Demand Webinar November 26, 2024Come and join us for this webinar, as our speaker and moderator highlight the impact of caregiver burden, discuss challenges in recognizing agitation in Alzheimer’s dementia, and share tools that…
-
Treatment Pathways Across Cultures
On-Demand Webinar November 25, 2024During this webinar, Sr. MSL Dr. Michael Aldape will be talking with Dr. Crystal Clark and Dr. Mauricio Tohen as they guide us on a lively discussion addressing the impact…
-
Neuroprogression: Understanding How Mental Health Conditions Can Progress Over Time
Infographic November 14, 2024This infographic aims to educate patients and caregivers on the importance of early diagnosis and treatment of mental health conditions and to emphasize how delays in diagnosis and treatment can…
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: